Transcatheter ablation of nodal tissue is used for the treatment of ar
rhythmia resistant to medical therapy. We have investigated the use of
laser induced fluorescence spectroscopy for the in vitro recognition
of nodal conduction tissue. Twelve fresh human necropsy specimens (< 4
8 hours) were obtained from sinoatrial node and atrioventricular node
areas. Spectra were recorded during excitation at 308 nm (XeCl excimer
laser, 1.5-2.0 mJ/pulse, 10 Hz). Each area examined was marked for su
bsequent histologic examination. Four hundred eleven spectra were obta
ined, of which 37 contained nodal conduction tissue (21 sinoatrial, 16
atrioventricular node). Normalized fluorescence emission intensity fr
om these areas was compared with that of surrounding endomyocardial ti
ssue at 18 wavelengths and 35 ratios of fluorescence intensity at sele
cted wavelengths. Spectra recorded from nodal tissue could be clearly
distinguished by a visible decrease in fluorescence emission intensity
at wavelengths from 440 to 500 nm (P < 0.0006 at 450 nm), peak area,
and peak width when compared to that of adjacent atrial endomyocardial
tissue. Nodal conduction tissue was also distinguished from ventricul
ar endocardium (14 spectra) by an increase in fluorescence emission at
430 to 550 nm (P < 0.0001). The specificity was 73% and 88% and the s
ensitivity was 73% and 60% for sinus nodal and atrioventricular nodal
conduction tissue identification, respectively. A ratio of fluorescenc
e emission intensity > 1.3 for 380/475 nm was able to detect nodal con
duction tissue (P < 0.001). Conclusion: Laser induced fluorescence can
differentiate nodal conduction tissue from atrial and ventricular end
ocardium and may provide a new diagnostic tool for the recognition and
subsequent ablation of nodal conduction tissue.